Media Coverage header image

Media Coverage

Advanced Search
  • 10182022
    Applied Clinical Trials

    Decode Health has announced a new phase of its collaboration with Quest Diagnostics. In earlier phases of the collaboration, the two parties developed RNA (transcriptome) sequencing capabilities.

  • 10172022
    PR News

    Recent research shows more messaging about cancer screening is needed. This is because diagnoses of prostate and breast cancer remain significantly below pre-pandemic levels. While this may sound like good news, it's not. The lower figures are due to a reverberating trend stemming from the pandemic. Based on data from 1.1 million patients, a Quest Diagnostics' analysis found cancer diagnoses plummeted nearly 30% in the first months of the pandemic in 2020, when much of society and healthcare were shuttered.

  • 10132022
    ROI-NJ

    Quest Diagnostics said it recently joined forces with a free H.O.P.E. Clinic in Plainfield operated by Rutgers University to help reduce health disparities in a community with a high percentage of uninsured adults by providing free lab services. Not only is this helping people with chronic conditions receive the treatments they need, but it also is helping to keep health care costs down by giving people an alternative to emergency departments.

  • 10112022
    Chief Executive

    Recent research suggests a mainstay of HR strategy—benefits, particularly those related to employee healthcare—is underrecognized for its potential to influence recruitment and retention. According to the 2022 Health at Work report from Quest Diagnostics, workers at companies with 1,000 or more employees say the quality of a company’s benefits for physical and mental health largely defines its attractiveness as an employer of choice. When asked to cite the top two factors for attracting and retaining workers, half (50%) cited comprehensive health insurance, making it the highest rated factor. And this makes sense given how expensive, complex and critical healthcare is for employees in the U.S.

  • 10112022
    Katie Couric Media

    Alarming: A new study from Quest Diagnostics has found that cancer diagnosis dropped 11.2% below pre-pandemic levels between April 2021 and March 2022, and breast cancer diagnosis fell even further, by 17%. This suggests that women are still delaying mammograms, meaning thousands could be living with undiagnosed breast cancer. Here's when you should get your first mammogram.

  • 10062022
    Reuters

    Faced with a shortfall in applicants, employers across the U.S. are balancing pressure to ease up on testing for a legal drug with concerns that this could impact safety and raise issues of liability. The challenge of balancing workplace safety and the growing prevalence — and legalization — of some types of drugs is especially acute for manufacturers and others who use dangerous equipment. Data from Quest Diagnostics, which handles testing for companies, shows a steady increase in positivity rates for marijuana tests over the past decade — coinciding with the wave of legalization. In 2012, only 1.9% of workers not subject to federally mandated drug testing requirements failed a pre-employment screening. Last year, that had grown to 4.1%. The jump in positive tests after accidents grew even more during that period, up from 2.4% to 6.7%.

  • 10062022
    Clinical Lab Products

    The first EUA for a proprietary monkeypox test was issued to Quest Diagnostics, Secaucus, NJ, on Sept. 7, 2022. “It’s an important step in identifying, treating, and, hopefully, eradicating monkeypox as we go forward,” says Damian “Pat” Alagia III, MD, MS, MBA, FACS, FACOG, chief clinical officer for health systems as well as the senior medical director for advanced diagnostics and women’s health for Quest Diagnostics. “About the time we got the EUA, we started to see a flattening of the curve of the trajectory of the disease, primarily because, concurrent with the EUA, we saw vaccinations starting to go up in the at-risk populations.”

  • 10052022
    Crain's Cleveland Business

    Under the agreement, Quest's laboratories in Twinsburg and Pittsburgh will provide testing for physicians and patients of the outreach lab services business, known as LabCare Plus. Summa Health will continue to wholly own and operate its hospital labs.

  • 10032022
    EHS Today

    With an increase in usage, and an increase in some states restricting employee testing, how will companies balance rights and safety? People are testing positive for drug use in the manufacturing sector at a higher rate. The most recent Quest Diagnosis Drug Testing Index survey found that from 2020 to 2021 overall positivity, which includes a number of drugs, increased by 4.5%. Looking at that number from 2017-2021 it was an increase of 28.6%. This survey is based on more than 11 million drug tests and covers a variety of industries, however, for this article, the data comes specifically from the manufacturing industry. “The largest driver for the increase is due to marijuana,” says Barry Sample, Ph.D., Senior Science Consultant for Quest Diagnostics.

  • 09302022
    Physician's Weekly

    Dr. Jeffrey Dlott shares lessons 1 year after the National Kidney Foundation removed race from the kidney function equation. Since the COVID-19 pandemic first began, gaps in care across the United States have magnified exponentially. Long-standing disparities affecting different racial and ethnic subpopulations reached the forefront of public consciousness, with COVID-19 demonstrating the critical role of social determinants of health on care and outcomes.

Show 5102550100 per page